[{"run_id":"20260906T231458-5fdd2fff","semester":"1272","observed_at":"2026-09-06 23:14:58.172943+00:00","record_version_id":"2f390492c4b6d659645d153e2a5f5979beea13a7a3069937d1e187a035ee31d9","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"20260907T155543-ce3781c4","semester":"1272","observed_at":"2026-09-07 15:55:43.033547+00:00","record_version_id":"2f390492c4b6d659645d153e2a5f5979beea13a7a3069937d1e187a035ee31d9","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"20261014T203208-0851c9a1","semester":"1274","observed_at":"2026-10-14 17:50:09.728220+00:00","record_version_id":"42f524a314cf92de0603eaa3044aa77c052fb71a583efc065576bba251899b8b","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6f575c8c32f4f0d6adc450c41798903e41e776605b02ae83003666b1523ebd9","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:40.829873+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/h_oncol/\",\"term\":null,\"text\":\"Demonstrate understanding of innate and adaptive immune interactions with tumors\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:40.829873+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/h_oncol/\",\"term\":null,\"text\":\"Apply understanding of immunology to understand immunotherapeutic approaches in cancer\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:40.829873+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/h_oncol/\",\"term\":null,\"text\":\"Compare and contrast therapeutic mechanisms of diverse immunotherapies\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:40.829873+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/h_oncol/\",\"term\":null,\"text\":\"Demonstrate knowledge of the patterns and rates of response to immunotherapies among distinct cancers\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:40.829873+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/h_oncol/\",\"term\":null,\"text\":\"Demonstrate understanding of immunotherapy toxicities and approaches to treating these\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:40.829873+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/h_oncol/\",\"term\":null,\"text\":\"Apply and adapt understanding of tumor immunology and current immunotherapies to devise a proposal for next generation approach to cancer immunotherapy\"}]"},{"run_id":"legacy-03b0bbb9723907cf3d1b41cf0bb34837dc398e42","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"7c9a1e267529439926aa6c869ceac293fb33c3a70dda8e4d45620979854e2b63","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0837245627eb714ae6bb0375f7abe8f41042011f","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"7c9a1e267529439926aa6c869ceac293fb33c3a70dda8e4d45620979854e2b63","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-08c92e359bbbc110b0778b7e0b15d6f40000e6b1","semester":"1262","observed_at":"2025-08-21 07:05:14.730696+00:00","record_version_id":"d1bbbf3fc8ae7fbc6e9bde9e14766e646aa4d58285e312e5ba0e7aad33271b06","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0944d76440dc778fbb89626058c10451009ce9c6","semester":"1262","observed_at":"2025-05-21 03:36:18.194118+00:00","record_version_id":"8e9375a32cebb847780ab0f31ee40e484c4e1e3c78a52cf55ed8a07b8896b91d","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0a7f4bce29c816ef4d3d71b4eb8a2a3e15e33cc1","semester":"1262","observed_at":"2025-06-18 20:04:02.695444+00:00","record_version_id":"48e37abb199f1e1787c3996a22c2c089c619a64021f9afb405412cc2dea18193","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0ab917f827a7de22ebdc1087114d377a31c4687b","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"c0ba96578391d2f2073257bfd0b0528e24c13ff10fa937e1da7baaedde5a38a9","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0c40ecab4b6db9333d1f18aef816e3ee659e300c","semester":"1262","observed_at":"2025-05-25 18:02:34.797617+00:00","record_version_id":"4c6d57fe20071f3479aee534ee6dfc32f7a82162b3358a61a84fc8458588df66","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0cb4d29a588ec7f11c7e00b7cf5dc3a0d23d0349","semester":"1266","observed_at":"2026-01-22 01:00:26.555427+00:00","record_version_id":"1b1e62d11494fc9c68c82615397b009a2938a6a523be1bdd54f9d2fddee96f0b","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-11c30ec39e91498cbfcf3a923c53a4b03e387280","semester":"1262","observed_at":"2025-07-20 04:58:26.847117+00:00","record_version_id":"0c162f7b2d8c58e92e7b8b31f4aa147d830290fb4fde2c413eda7bddb5afce40","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-13cd500edf2587e9a3428f326253738fbea965ea","semester":"1264","observed_at":"2025-12-14 04:50:04.653658+00:00","record_version_id":"74d0432f4077a6bf71ed2e97ecc8c386b49953a5178918d0d817a29d46d0e5af","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-1da08b2de39f05e6bc877c189fc2fd6eeda563f5","semester":"1262","observed_at":"2025-07-01 00:03:56.707251+00:00","record_version_id":"1e6afe03d685e5282efaa006c2255d289308e40d710baaed680877b09f3019d0","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2031af47efe133b0e7877f433286ff07385afc41","semester":"1262","observed_at":"2025-07-02 20:16:45.749584+00:00","record_version_id":"aaf9b5f21dcdc924ab940256d8ddd371c6b8000f1ac1675aa480b8517d8f9b80","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-238eba6f32fbc30407f616dd0628ff02a2a824dd","semester":"1262","observed_at":"2025-08-17 05:15:07.788352+00:00","record_version_id":"4c9c6b3708fd5e5b6b5d1469495371c1729fe10929b9fb0e60d2679ef186d183","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-25f0ff56bc4d80f8a8afa1a0bcce8dae6fddb5e5","semester":"1262","observed_at":"2025-05-25 17:20:25.942090+00:00","record_version_id":"ccea5e43cbb7a2007cd7d3aa15c499e50bc6c611c620cc7f10b5064e65c535b6","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2923f91826ce253b7aeefa9f75b4a39fe4c80ff0","semester":"1262","observed_at":"2025-08-10 05:10:25.938416+00:00","record_version_id":"ddaa17d0df6d0cbfcb2883d51af7f31ac40407420f53ee8071e34908eaf19261","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2a05214a4023e0157fa6f7d188c85308f714176c","semester":"1262","observed_at":"2025-09-07 04:56:38.255315+00:00","record_version_id":"1580d09f97f7ba29527539de19cf9bf5a35094fa5b6fdba6565d775176006082","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2b1b8e39131de92b94620b25c5bbb25690efed4c","semester":"1262","observed_at":"2025-06-01 07:54:53.913454+00:00","record_version_id":"3365a1eceb0bb84a1510b782cc825c613abfc0e9630dbe0d3b7026fcfa9dd426","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-33a1225644e5a5855d60f66e65413946e72fedf4","semester":"1262","observed_at":"2025-06-22 01:52:05.152650+00:00","record_version_id":"c01f437f1a0218428134cab66954630db5b60b408af2b9c91b820232eaaf19c3","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3b89c83dbf5208e13756184de1f2b2d0c09af35f","semester":"1262","observed_at":"2025-06-30 06:40:10.235522+00:00","record_version_id":"a6eaaa1d81d3b235c8fef0e73772f8823dca295ac9185bc343d778deb7ca11c7","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3c3eebf7f35c39364b445a2fa5a112ce28dbb4a1","semester":"1262","observed_at":"2025-06-01 17:03:59.062985+00:00","record_version_id":"11483fe8b0ac5d799ce3e9359b7ebd2aef589c2634d17d8f33fadc6cb0f5aaa7","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3fa4dd71391f1c9cf4ab2216680bbc428689f92d","semester":"1262","observed_at":"2025-05-25 01:15:58.180530+00:00","record_version_id":"7ed523087b07a119f2ecde1e649f6d819dcf6eec223f4f9ad36801eb7d2fb8a4","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-4040aa216da722a34483f68fc1e129ea571ae08d","semester":"1262","observed_at":"2025-06-01 07:27:39.695506+00:00","record_version_id":"cd25f66a3f2b1c17cb5f64058bebd9ecbbf8f6978b1128ee3511170736686d75","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-454d53cd690294459f8ad0793cc3ed562060e56c","semester":"1262","observed_at":"2025-05-25 01:34:00.536004+00:00","record_version_id":"78496f9e80d2a114a751f31536511c1298efd95b67e159ea54d42110fc0be140","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-486f091e051fdb4ccdb80ee7b4fb0a5814510324","semester":"1264","observed_at":"2025-11-16 05:32:31.273726+00:00","record_version_id":"dc5bc887385076078343c8ea63bfc39a69ad2b076f2406a32c5067c1da878117","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-50393cfc5fd5598d4f4731ef1919f2ff53af07d9","semester":"1262","observed_at":"2025-06-30 06:05:57.438846+00:00","record_version_id":"94e618eb51458832a0a895adff13852f9e29cf9cc9d6777a53b1abab26581247","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-50f6947786b208c800db8bbd0cec84a8f0f187d2","semester":"1262","observed_at":"2025-06-02 03:49:42.915428+00:00","record_version_id":"7ffb1c502e7423b03ff7955b6ad2e3df2a05a1137e8fa07f999660065e8872e0","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-51d86ed4082dced3803c295419b0ec8440942016","semester":"1264","observed_at":"2025-11-12 04:50:41.141307+00:00","record_version_id":"5ec2dc87bbca2dca39634c128b0e2c68d95a7745989adb564f7ef40c509385a1","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-53101bd1c10db0d00d094e4c9154d4c244ff23d9","semester":"1262","observed_at":"2025-10-05 04:58:05.366968+00:00","record_version_id":"d99925037897b5268ff9f6bf0904957b0423447c6b96cc7f7067d3cafa6ea80a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-58751151c564e11c5cb8aedd3a2d3527c22f73eb","semester":"1262","observed_at":"2025-06-01 06:59:01.536576+00:00","record_version_id":"254954a0e640da1005f9c394d54c8f65fd4750914c4962d32167a1e92c088c64","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5c4c8d3701a333ba4ddadef7d0b5dde8440fcdf0","semester":"1262","observed_at":"2025-06-01 01:57:51.256704+00:00","record_version_id":"630cdc291453af14e8a58c9ba9d7e184837fe0646ae0893a4c1011e8584943b0","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5d20d9f81651d3c83fcaa2fd10870ce6e5d5a685","semester":"1262","observed_at":"2025-05-21 16:48:48.484741+00:00","record_version_id":"e4fbef57b47bd64fd26479dafcdb1288df0b0c528932fd47631da7bc1bba1999","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5feaebf2ab37051c86ad360cc0fa0d7e0e2ea295","semester":"1262","observed_at":"2025-05-24 15:58:23.378859+00:00","record_version_id":"928adc801ba806085269ea7fd5c345abba97abcce145030e91f9e51d6d345286","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-60949965544fce098cc006354e201149005fb77b","semester":"1264","observed_at":"2025-10-26 05:07:14.077864+00:00","record_version_id":"45b960e3b4382331c9d39b6b61a899f998482a6cc3d5ca5ea814ebdb1efc6e5a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-639225ac3addf8522f1d30cb4fe26054ea7f8c49","semester":"1262","observed_at":"2025-06-01 08:14:42.497608+00:00","record_version_id":"a474dcee2b123ec9b156569868878f5f20d814e72481bc1c45907f45b8c19d62","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-64093b17b3a9c67a41aa33eb37adb53ec38df714","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"f527384a20908d1ba3960f99c4852ae830e701406f100b9bbe6a87aa546f0d70","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-6885b56099f55e08aa0205546369fb0381d50e13","semester":"1262","observed_at":"2025-07-13 04:59:22.367394+00:00","record_version_id":"f668226b17798813c6ddfce6c50302d963c95deb3ea7af82ca5fd9de23e75b5f","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-69d4b2b16e8268f75b6390b3a0e2ce8bf73999da","semester":"1262","observed_at":"2025-06-30 03:21:29.925498+00:00","record_version_id":"bbccff2df84c76c9ada2e7c1cc4c45fb0c106c1f4157d8da46e9baf4ce1f8c1f","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-6b29c3e0673b2f9a736d2363db5409e03d5b3ed4","semester":"1264","observed_at":"2025-12-03 12:33:41.418072+00:00","record_version_id":"e7e18f7739f5f7e3ae60579c3490cc1610b3e4f4c3fb419b10d4e928e2213065","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-73259984748de484976ef2ad56ad7ab3d4cb4518","semester":"1262","observed_at":"2025-06-26 08:27:56.461216+00:00","record_version_id":"2796411ad59fc02c18b230ecea0f2c8ca642d91d8bb4dc995ae2f507c5cc5125","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-741602fbc6252c232a0b9e6bc1a9ae3101625f5a","semester":"1262","observed_at":"2025-06-30 22:49:32.522034+00:00","record_version_id":"f5e54755e8ed2c65703c5016d9ee1a77f6855fa20bed8761caa2cc94d2ab6570","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7774f45558276ec29bf626e58fffb4a27bdbb2a9","semester":"1264","observed_at":"2025-11-01 11:49:36.359151+00:00","record_version_id":"18b804a69d447bffdca6d475057ed65d383cf87f3f28079d1ab0710dfa622074","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7ab7c5e783fc8ebef8b8ee8cea019ee37a72ce74","semester":"1262","observed_at":"2025-09-28 04:58:07.340658+00:00","record_version_id":"14dca4663dee3d26f35e3ec4cb68bd826aab6c648430eb5d87c35eb321de2b3b","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7b2f22d83ea05055ab90dcb77dc802382cccc6f7","semester":"1262","observed_at":"2025-05-21 17:56:46.096741+00:00","record_version_id":"cf2a546ea2f69fc8cd159b99ad4a7a19f64308097eeb9dfc0fdd5b196ff47621","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7ca1175502be18eb51f7b016818a884a43fd4ebb","semester":"1262","observed_at":"2025-07-29 06:28:23.644795+00:00","record_version_id":"c984a186addceef73c23d56a01f2e0d98adb67fae13bb62160dcefed67d4f46a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7d8cee5e42602ad9ba5dc0322085af2fa0dffaac","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"857c1abf6832faa306d5db496146bd2e305c9cff379d757c4a8508bd8377e8c2","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-81a0d6a7f668c98c59bd05fa988aa079c5ad1f68","semester":"1262","observed_at":"2025-05-31 07:49:50.419452+00:00","record_version_id":"9fa84123e8b9fdcbe0ca95d24ce4e3f3ec3bf0b0fba3e406d14cba21e3434c55","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-82f31c08c746a214872494cde6ecaeb9330441b4","semester":"1262","observed_at":"2025-06-17 21:26:08.547156+00:00","record_version_id":"f7d5b451181c6de27cb35f39fabfe757af60ac26da00981a37b88d896cc2a51d","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-84c248343c5a99ab42c5616c594812a5e3e31cbb","semester":"1262","observed_at":"2025-07-04 06:00:07.487827+00:00","record_version_id":"64d1c862f8746da3da5b7fc5806f2b97d7c100d43ab78e5e97581ea6a154bc8c","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-86334e7275e315853287e8580c35456c68df800b","semester":"1262","observed_at":"2025-05-22 06:53:03.336354+00:00","record_version_id":"87affb1466566c4db6a0c183953981dcae0989869e89921d57c5166acf206604","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-8686dc1664f93a6c05f50321410961b39b12f91b","semester":"1262","observed_at":"2025-05-28 10:17:41.595894+00:00","record_version_id":"b6ca0abb388119f8cc74fcbcf90e340a202f4a1ad196c566f4de74991f4decb1","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-86d941366886c9a14a2581c04e20d0bdd25e1b02","semester":"1262","observed_at":"2025-08-31 04:54:14.656039+00:00","record_version_id":"b87b4bc17cd26e2418cc97566c028bcd9d362fe3ea1bf952d93704096e23460a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-8ba1d2e6cfbb1525b4f9f769ec164fb6ad0f237a","semester":"1262","observed_at":"2025-06-02 05:22:45.010398+00:00","record_version_id":"bfbf1910e503a1bdda397e7e6e31b8fa001fc1215c9ecdbdf73ce2598dbf8d9a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-90e5aa456689a3b222016c05c319bbcd0bddd453","semester":"1262","observed_at":"2025-05-25 02:00:10.037905+00:00","record_version_id":"841dbde321592f76fb071d564f0424880ac3707d70875e838eb65032995ac724","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-92d960aa7e4cd6e4c9ac8b2e232092904038e9e4","semester":"1262","observed_at":"2025-06-08 01:50:46.451351+00:00","record_version_id":"a066cf4bc88e6789fc3aaa296fded0856451d50ace53367828c9f3804916c4b9","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-94002ae588a8f71eca6d64105f2e603e8587293b","semester":"1262","observed_at":"2025-05-21 09:01:16.021508+00:00","record_version_id":"21ea5fa08bf7f64cef8406030a347a3b14af98ada89110115e500231dc59f24f","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-9dd575e013c5c6e000ab3ad2d1288cc1dd9c96dc","semester":"1264","observed_at":"2025-12-21 04:47:46.589081+00:00","record_version_id":"054685d813a21bb5da1b5cfeaaeafe4a5c5e627753efa377d6ec3c9ca1edd3ff","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-a1ea26ed78cbd6e94bc3221e50a6ed9b6bf43871","semester":"1262","observed_at":"2025-05-25 09:16:55.180581+00:00","record_version_id":"e0a85037cdb57deb0e9a7f8df2636e4ab287e671de97032eaa220302e591eb48","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-a76a3505853d5ea9c13bb98472b87361d469e2ee","semester":"1262","observed_at":"2025-05-28 18:03:41.793846+00:00","record_version_id":"c160e0a7fbe9688c708ec89c9dd8e50ac0a36454fb041af1f825555bada66366","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b285d591f6acf3aa1910e02edc297664db86eb8c","semester":"1262","observed_at":"2025-06-10 22:48:22.460295+00:00","record_version_id":"fa464d2171f06381e8eac3c58632edab10543ee009781f5cb26df13e17f44610","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b79af756e4f00ba98231feb859ed8e98239eb811","semester":"1262","observed_at":"2025-05-22 02:47:56.931581+00:00","record_version_id":"bb4f7b827068f2836040f9e626cb8c2f89894b56133ee4b48a36f337de25979a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b89e05b94730c6471439082d9279c0a834a4aeec","semester":"1262","observed_at":"2025-08-26 20:25:42.325239+00:00","record_version_id":"a4b9fc15c716a7cb682fe110977a27973d095c97b463f06432ffeb0edb1a8b18","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b9279a12d1f2688df9e556183c94d41a89e431dc","semester":"1262","observed_at":"2025-07-06 01:49:47.203835+00:00","record_version_id":"5472052da0fa8d053413d1fead89c17bea28df2a07ef482b30322005f572f190","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-bbdc905e96cc681a5e9a8b02c795b682206e36d1","semester":"1262","observed_at":"2025-06-25 08:02:45.445730+00:00","record_version_id":"7e555e28dc190159b7211934747f567d129cdccd2a2d3b032575c1e089857208","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-bde225b5243a13d81827aa173e39c78a652b54a0","semester":"1262","observed_at":"2025-05-23 07:22:33.219345+00:00","record_version_id":"763a399263b19eabf941e2c7f4d08ff8115a7073b9b2c172ee080140053fef66","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-c1fac4cbfde737f4f4ac02cdf15e6f5a9b5b676d","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"857c1abf6832faa306d5db496146bd2e305c9cff379d757c4a8508bd8377e8c2","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-c6b62be45f8a13cba109ef2a7741b9cd9a6b8272","semester":"1262","observed_at":"2025-08-24 08:48:09.035112+00:00","record_version_id":"dfb100e552775d2f98bc456a741491e5bd724cfbfe1bd2b43ba269dbf4e296bc","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-cc83f62cb6db61f39320916d819ad48ce55cd96d","semester":"1262","observed_at":"2025-05-22 00:45:35.735230+00:00","record_version_id":"40aef5d54d1aad0c4cd78b17e581089ffc76cf837598b54a44cc2a07e81af89a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d33818a01b6b4c5e2902e704da6e5b713742d4dc","semester":"1262","observed_at":"2025-10-13 10:46:24.251475+00:00","record_version_id":"fb0abb8f1379ce33614b5c87e013b9647dce20a82b51348066111c31c431c5ac","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d3c17db9832d3064916046caf891dd23f10b1bb9","semester":"1262","observed_at":"2025-08-26 11:30:42.288639+00:00","record_version_id":"66e719e796a8fe85458d42115ea6d9ba1e9f33ce6f8936b157607e364e386520","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d4ee226dc44268e9b6767fb9f5f20343322f494b","semester":"1262","observed_at":"2025-06-15 01:52:23.911697+00:00","record_version_id":"4bfde65564a542462c0c63111842c9a2d9ae2f6b3e1369378f74413006c0d6ec","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d8f9fc7f136e2033556d9d65bbdbdf33425dbdc9","semester":"1262","observed_at":"2025-05-28 16:48:12.400438+00:00","record_version_id":"b0b2897bee239173c2c00c11c489b08e6db7d980f1421a59536e47b39887406f","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dbbc9739c616c3846b2e796e00a36fa41225f7d8","semester":"1262","observed_at":"2025-06-01 17:47:19.325144+00:00","record_version_id":"342305fc68cbf8e9ea609d8b60647acea0ca06ccb6c1e4980835806a27f4da0c","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dbe5f2d24b48c3177297a3d69c553cc9d1194bac","semester":"1262","observed_at":"2025-09-14 05:00:27.366070+00:00","record_version_id":"58fcba5108e06c82d0531f37364e6657f3336798e63c81988161d873911ef5d4","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dd357dc2758e9e282c30988a527ce37de92593b9","semester":"1264","observed_at":"2025-10-19 01:39:41.951404+00:00","record_version_id":"685a5f4ed572700d929650de72ec419b790c188a4874bd913aa21679dc90fb68","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-de74de559e409a3fe668685e28043b888d2e6841","semester":"1262","observed_at":"2025-06-27 07:38:50.882897+00:00","record_version_id":"3b6ff945863fcf6bfd7dc9acd82c0840ef5221991ecb7cd0997ce38679f8f446","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-deca7188cf536ade3203cd88b52a45e92a059617","semester":"1262","observed_at":"2025-06-27 00:37:46.087071+00:00","record_version_id":"df3cac4872f983e563ac20b476dfff0b10cc1869ef03412ef95d6484000c1221","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-df60fa9ac3931c5612b0fa641b7a6f5fbec86fab","semester":"1262","observed_at":"2025-05-24 06:36:37.554678+00:00","record_version_id":"aadfb2961b08b8a1488413bfb08a37ae27a475b9a6bea30e72b9743d35e8e5ed","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-e339da2d849aaf8bb4dceca07a84728af23cf755","semester":"1262","observed_at":"2025-07-23 08:49:22.748925+00:00","record_version_id":"9d817309df9e1fd418a6009d580f78730393989aa1266c79990fcdc55f8f494e","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-e934b1784835f5d36ae9b7ef0992b11e72c39142","semester":"1262","observed_at":"2025-06-01 06:21:25.219533+00:00","record_version_id":"2603e5f4a33739580d2e0419f4d675aa1237015f24757efbc62a161cbe88ad79","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-ef471690c082448deebd2687eab84b0b78813c36","semester":"1262","observed_at":"2025-06-29 01:47:56.317645+00:00","record_version_id":"7cdaf0c3a066941c96ef810a0fe8e852b35bfe8033976451d10982ee7a4eb97c","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-efc4e8e2cd7c3f68e059a308990c00c77c7611eb","semester":"1264","observed_at":"2025-10-16 05:48:13.935141+00:00","record_version_id":"a9f0c7a47571198b715be26141bd4978bd62bf48ac67823657feae339935ddf1","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"},{"run_id":"legacy-f18b7749725097d41f69c60779ff38cf073b93b3","semester":"1262","observed_at":"2025-05-21 19:52:03.259353+00:00","record_version_id":"68e7cb654b9c5fb8cf2ce49baf8b01e6b4b67183d5ccf57399d7db6ff1f98c43","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813","official_learning_outcomes_json":"[]"}]